Australian Researchers Launch Program to Combat Emotional Burden of AF

A new initiative from the University of South Australia aims to address the emotional challenges faced by thousands of Australians living with atrial fibrillation (AF), the most prevalent heart rhythm disorder globally. Supported by a $150,000 Heart Foundation Vanguard Grant, the study will develop and evaluate Australia’s first psychological support program specifically designed for individuals with AF.

The research, led by Professor Hannah Keage, seeks to alleviate anxiety, a significant issue for up to one in three patients. “Atrial fibrillation can be unpredictable and frightening,” Prof Keage stated. “Many patients live with constant worries about AF symptoms recurring and progressing, as well as the risk of stroke or heart failure. Yet, despite this heavy emotional burden, there are currently no psychological support programs designed for AF patients in Australia.”

Worldwide, AF impacts approximately 40 million people and notably increases the risk of stroke, heart attacks, and even dementia. Beyond these serious physical health concerns, individuals suffering from AF often grapple with anxiety, depression, and emotional distress. While psychological therapies have shown effectiveness in other cardiovascular conditions, such as coronary heart disease, no similar interventions have been tested specifically for AF patients.

Innovative Approach to Patient Support

The two-year project, set to commence in 2026, will be conducted under the Adelaide University banner, in collaboration with the University of South Australia and the University of Adelaide. This partnership aims to create a new major university, expected to open next year. Using a co-production model, the initiative will ensure the program accurately reflects the needs of AF patients.

Researchers will work closely with individuals living with AF, along with cardiologists, nurses, and allied health professionals, to formulate the program’s design and content. Feedback from patients earlier this year revealed that many receive minimal information regarding the emotional impacts of AF. Numerous participants described feelings of isolation and being in “survival mode,” struggling with the unpredictability of their symptoms and concerns about their long-term health.

“Consumers told us they want information, reassurance, and practical tools,” Prof Keage explained. “They need to know what’s normal, how to respond to symptoms, and how to live confidently with AF.”

Trial Phase and Long-Term Goals

Once the program is developed, it will be trialed with 30 patients recruited through the Cardiovascular Centre in Adelaide, Whyalla, and Port Lincoln. The aim is not only to improve psychological health but also to enhance treatment compliance, reduce symptoms, and support long-term heart health.

“Improving psychological health doesn’t just make patients feel better. It can also improve their treatment compliance, reduce their symptoms, and better support their long-term heart health,” Prof Keage noted. This research has the potential to significantly transform care for AF patients across Australia.

For more information, please contact Professor Hannah Keage at [email protected] or media representative Candy Gibson at +61 434 605 142.